跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEIJUMET PROLONGED RELEASE TABLET 750MG - HSA Drug Approval Details
Approvals
/
HSA
/
MEIJUMET PROLONGED RELEASE TABLET 750MG
Approved
THERAPEUTIC
MEIJUMET PROLONGED RELEASE TABLET 750MG
Medreich Limited
🇸🇬 Health Sciences Authority
Approval Date
Apr 26, 2018
Approval ID
516bd477b1a2901c
Company
Medreich Limited
Type
Therapeutic
Approval Details
Approval Id
516bd477b1a2901c
Drug Name
MEIJUMET PROLONGED RELEASE TABLET 750MG
Product Name
MEIJUMET PROLONGED RELEASE TABLET 750MG
Approval Number
SIN15471P
Approval Date
2018-04-26
Registrant
PHARMAZEN MEDICALS PTE LTD
Licence Holder
PHARMAZEN MEDICALS PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
A10BA02
Atc Item Name
metformin
Pharma Manufacturer Name
PHARMAZEN MEDICALS PTE LTD
Company Detail Path
/organization/pharmazen-medicals-pte-ltd
Active Ingredients
Metformin 585mg eqv Metformin Hydrochloride
750mg
METFORMIN 585 MG EQV METFORMIN HYDROCHLORIDE
750 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 26, 2018
Approval ID
516bd477b1a2901c
Type
Therapeutic
Back to HSA Approvals